To determine whether PARP1 overexpression contributes to the survival and/or proliferation of ovarian cancer cells, we applied PJ-34 to cultured cancer cells, A2780, HEY and HO8910, and evaluated apoptosis and cell cycle progression. Here, PARP1 is linked to ovarian carcinoma.